Levita Hidayat
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 8
-
- Antibiotic Use and Resistance 9
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus 3
- Molecular Medicine top 5%
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Cystic Fibrosis Research Advances 3
-
- Innovations in Medical Education 2
-
- Drug Transport and Resistance Mechanisms 2
-
- Pharmacological Effects and Toxicity Studies 2
- Co-authors
- Donald HsuRyan QuistAnnie Wong‐BeringerKimberly ShrinerJanet HindlerÅsa KarlssonMichael BolarisJason Yamaki
- Partner nations
- United StatesSweden
In The Last Decade
Levita Hidayat
18 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Clinical Biochemistry 575
- Applied Microbiology and Biotechnology 154
- Infectious Diseases 737
- Molecular Medicine 105
- Pharmacology 302
Countries citing papers authored by Levita Hidayat
This map shows the geographic impact of Levita Hidayat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levita Hidayat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levita Hidayat more than expected).
Fields of papers citing papers by Levita Hidayat
This network shows the impact of papers produced by Levita Hidayat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levita Hidayat. The network helps show where Levita Hidayat may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Levita Hidayat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 6 | |
| 2 | 2021 | 2 | |
| 3 | 2021 | 60 | |
| 4 | 2021 | 46 | |
| 5 | 2021 | 2 | |
| 6 | 2020 | 3 | |
| 7 | 2018 | 3 | |
| 8 | 2016 | 24 | |
| 9 | 2016 | 11 | |
| 10 | 2016 | 9 | |
| 11 | Quantification of curricular content devoted to point-of- care testing for infectious diseases in schools and colleges of pharmacy in the United States | 2015 | 4 |
| 12 | 2012 | 28 | |
| 13 | 2012 | 50 | |
| 14 | 2008 | 32 | |
| 15 | 2008 | 16 | |
| 16 | 2008 | 22 | |
| 17 | 2008 | 144 | |
| 18 | High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus Infectionsbreakdown → | 2006 | 691 |
About Levita Hidayat
Levita Hidayat is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Geriatrics and Gerontology, having authored 18 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (9 papers), Bacterial Identification and Susceptibility Testing (8 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Cystic Fibrosis Research Advances (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Innovations in Medical Education (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Clinical Biochemistry (575 citations), Applied Microbiology and Biotechnology (154 citations) and Infectious Diseases (737 citations). Levita Hidayat has collaborated with scholars based in United States and Sweden. Frequent co-authors include Donald Hsu, Ryan Quist, Annie Wong‐Beringer, Kimberly Shriner, Janet Hindler, Åsa Karlsson, Michael Bolaris, Jason Yamaki, Esther Kim and C Andrew DeRyke.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.